NO20025844L - Ikke-nukleosid revers transkriptase inhibitorer - Google Patents

Ikke-nukleosid revers transkriptase inhibitorer

Info

Publication number
NO20025844L
NO20025844L NO20025844A NO20025844A NO20025844L NO 20025844 L NO20025844 L NO 20025844L NO 20025844 A NO20025844 A NO 20025844A NO 20025844 A NO20025844 A NO 20025844A NO 20025844 L NO20025844 L NO 20025844L
Authority
NO
Norway
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
nucleoside
inhibitors
Prior art date
Application number
NO20025844A
Other languages
English (en)
Other versions
NO323830B1 (no
NO20025844D0 (no
Inventor
Bruno Simoneau
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of NO20025844L publication Critical patent/NO20025844L/no
Publication of NO20025844D0 publication Critical patent/NO20025844D0/no
Publication of NO323830B1 publication Critical patent/NO323830B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
NO20025844A 2000-06-16 2002-12-05 Forbindelser, anvendelser derav samt inhibitor for HIV-replikasjon og farmasoytisk preparat NO323830B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21232900P 2000-06-16 2000-06-16
US25663800P 2000-12-18 2000-12-18
PCT/CA2001/000890 WO2001096338A1 (en) 2000-06-16 2001-06-14 Non-nucleoside reverse transcriptase inhibitors

Publications (3)

Publication Number Publication Date
NO20025844L true NO20025844L (no) 2002-12-05
NO20025844D0 NO20025844D0 (no) 2002-12-05
NO323830B1 NO323830B1 (no) 2007-07-09

Family

ID=26907019

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025844A NO323830B1 (no) 2000-06-16 2002-12-05 Forbindelser, anvendelser derav samt inhibitor for HIV-replikasjon og farmasoytisk preparat

Country Status (36)

Country Link
US (1) US6420359B1 (no)
EP (1) EP1294720B1 (no)
JP (1) JP3923894B2 (no)
KR (1) KR20030017540A (no)
CN (1) CN1178939C (no)
AR (1) AR028958A1 (no)
AT (1) ATE322492T1 (no)
AU (2) AU7037001A (no)
BG (1) BG107348A (no)
BR (1) BR0102377A (no)
CA (1) CA2411766C (no)
CZ (1) CZ20024114A3 (no)
DE (1) DE60118560T2 (no)
DK (1) DK1294720T3 (no)
EA (1) EA005598B1 (no)
EE (1) EE200200690A (no)
ES (1) ES2261433T3 (no)
HK (1) HK1057558A1 (no)
HR (1) HRP20021003A2 (no)
HU (1) HUP0301105A2 (no)
IL (1) IL152819A0 (no)
MX (1) MXPA02012205A (no)
MY (1) MY130375A (no)
NO (1) NO323830B1 (no)
NZ (1) NZ523549A (no)
PE (1) PE20020083A1 (no)
PL (1) PL360370A1 (no)
PT (1) PT1294720E (no)
SA (1) SA01220202B1 (no)
SK (1) SK17722002A3 (no)
TW (1) TWI270547B (no)
UA (1) UA74834C2 (no)
UY (1) UY26767A1 (no)
WO (1) WO2001096338A1 (no)
YU (1) YU94202A (no)
ZA (1) ZA200209807B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) * 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
CA2510143A1 (en) * 2002-12-16 2004-07-01 Boehringer Ingelheim International Gmbh Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors
WO2004087140A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
US7309700B2 (en) * 2004-04-02 2007-12-18 Boehringer Ingelheim International Gmbh Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en) 2004-08-02 2006-02-02 Boehringer Ingelheim International Gmbh Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en) * 2004-11-05 2006-12-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
WO2007067844A1 (en) * 2005-12-05 2007-06-14 Boehringer Ingelheim International Gmbh Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
EP2085390A1 (en) * 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
JP5643290B2 (ja) * 2009-04-09 2014-12-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Hiv複製の阻害薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

Also Published As

Publication number Publication date
PL360370A1 (en) 2004-09-06
HK1057558A1 (en) 2004-04-08
SK17722002A3 (sk) 2003-06-03
BR0102377A (pt) 2002-02-19
AU2001270370B2 (en) 2006-08-03
AR028958A1 (es) 2003-05-28
JP2004502787A (ja) 2004-01-29
ZA200209807B (en) 2003-10-16
KR20030017540A (ko) 2003-03-03
MXPA02012205A (es) 2003-09-10
ATE322492T1 (de) 2006-04-15
EA005598B1 (ru) 2005-04-28
US20020028807A1 (en) 2002-03-07
DE60118560T2 (de) 2006-09-28
HRP20021003A2 (en) 2005-02-28
CA2411766A1 (en) 2001-12-20
UY26767A1 (es) 2002-01-31
CZ20024114A3 (cs) 2003-04-16
ES2261433T3 (es) 2006-11-16
CA2411766C (en) 2006-05-23
SA01220202B1 (ar) 2006-09-05
HUP0301105A2 (hu) 2003-08-28
EA200201255A1 (ru) 2003-06-26
YU94202A (sh) 2005-11-28
PE20020083A1 (es) 2002-02-28
JP3923894B2 (ja) 2007-06-06
DE60118560D1 (de) 2006-05-18
EE200200690A (et) 2004-06-15
UA74834C2 (en) 2006-02-15
AU7037001A (en) 2001-12-24
EP1294720A1 (en) 2003-03-26
US6420359B1 (en) 2002-07-16
WO2001096338A1 (en) 2001-12-20
NZ523549A (en) 2004-08-27
NO323830B1 (no) 2007-07-09
TWI270547B (en) 2007-01-11
CN1178939C (zh) 2004-12-08
DK1294720T3 (da) 2006-07-31
EP1294720B1 (en) 2006-04-05
MY130375A (en) 2007-06-29
BG107348A (bg) 2004-06-30
CN1436189A (zh) 2003-08-13
PT1294720E (pt) 2006-06-30
NO20025844D0 (no) 2002-12-05
IL152819A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
NO20021042D0 (no) Benzofenoner som inhibitorer av revers transkriptase
NO20033857D0 (no) Benzofenoner som inhibitorer av revers transkriptase
IS6668A (is) Kolkínólafleiður sem æðamyndunarhemlar
PL378556A1 (pl) Nienukleozydowe inhibitory odwrotnej transkryptazy
DK1742908T3 (da) Ikke nukleosid revers transkriptase inhibitorer
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
DE60117597D1 (de) Aufweitvorrichtung
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
HK1111155A1 (en) Non-nucleoside reverse transcriptase inhibitors
DK1294720T3 (da) Non-nukleosid revers transkriptase-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
AU2003269628A1 (en) Non-nucleoside reverse transcriptase inhibitors
DE50100256D1 (de) Polybenzoxazol-vorstufen
DE60139831D1 (de) Sicherung
ATE276445T1 (de) Spreizdübel
NO20030248D0 (no) Tricykliske pyridonforbindelser anvendelige som HIV revers- transkriptase-inhibitorer
EP1047656A4 (en) NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS WITH A COMMON ALCENYLDIARYLMETHANE STRUCTURE
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
EP1326640A4 (en) NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR AS ANTIRETROVIRAL THERAPY
AR028075A1 (es) Inhibidores de la peptido-desformilasa
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
SI1294720T1 (sl) Nenukleozidni inhibitorji reverzne transkriptaze
NO20044043L (no) Dipyridodiazepioner som revers-transkriptase-inhibitorer
AU2002355614A1 (en) Non-nucleoside reverse transcriptase inhibitors